Clinical trials: Albuterol Effect
Chronic Obstructive Pulmonary Disease
The Effects of RPL554 on Top of Standard COPD Reliever Medications
This study evaluates the addition of RPL554 to standard reliever medications for chronic obstructive pulmonary disorder (COPD). All patients will receive the same six treatments in a randomised sequence: 1. salbutamol, 2.
- Trial name
- NCT02542254
- Testing
- Salbutamol, Ipratropium, RPL554
- Where
- United Kingdom
- Volunteers
- 36 people
- Sponsor
- Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Mild Asthma
Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma
The purpose of this study is to compare the efficacy and safety of albuterol/budesonide to albuterol in changes in airway inflammation, asthma symptoms, and rescue therapy utilization in adults with mild asthma.
- Trial name
- DARWIN (NCT06563102)
- Testing
- Albuterol/Budesonide, Albuterol
- Where
- 16 sites in United States
- Volunteers
- 101 people
- Sponsor
- AstraZeneca
Asthma
Symbicort Onset of Action 1
The purpose of this study is to compare the early onset of effect of Symbicort compared to Advair Diskus and Ventolin in adults with asthma
- Trial name
- NCT00646620
- Testing
- budesonide/formoterol (Symbicort), fluticasone/salmeterol (Advair Diskus), albuterol (Ventolin)
- Volunteers
- 48 people
- Sponsor
- AstraZeneca